Even with competition from Lipitor, introduced last year, Merck's sales of its Zocor anti-cholesterol drug topped $1 billion in the fourth quarter.

Study results also demonstrated VYTORIN increased HDL cholesterol by a greater degree than Lipitor In other results observed in the six week study, VYTORIN cholesterol lipitor 10/40 mg and 10/80 mg also provided significantly greater increases in HDL ("good") cholesterol of 9. 0 percent and 7.
6 percent respectively as compared to the HDL cholesterol increase of 3. 8 percent cholesterol lipitor and 1.

4 cholesterol lipitor percent respectively seen in patients taking Lipitor 40 mg and 80 mg (p<0.
28, 1997, according to Scott-Levin's Source(TM) Prescription cholesterol lipitor audit (SPA) Weekly service. The benefit could not be totally explained by the lower cholesterol levels. Third-party payers, such as health plans and union benefit funds, that have paid for Lipitor taken by people described above are also eligible to join this lawsuit against Pfizer. VYTORIN is marketed as INEGY in many countries outside the Cholesterol lipitor u. Warner-Lambert's fourth quarter net of cholesterol lipitor $235. 7 million, or 84 cents a diluted share, rose Cholesterol lipitor from $171 million, or 62 cents, in the year- earlier period.
Scott-Levin research reveals that Lipitor's market share among cardiologists grew at a faster rate, to 8. 8 percent, for the week ending Feb. Study cholesterol lipitor showed VYTORIN was well tolerated and had lower incidence of liver function elevations than Lipitor Both VYTORIN and Lipitor were well tolerated in the study. High triglycerides and low HDL cholesterol are both risk factors for cardiovascular disease (CVD); CRP is considered an emerging risk factor for CVD. High risk patients in the study with a goal of less than 100 mg/dL who were taking VYTORIN 10/20 mg had a baseline LDL cholesterol of 166 mg/dL as compared to patients taking Lipitor 10 mg who had a baseline cholesterol lipitor of 169 mg/dL. "These results are consistent with what was seen in the overall study. " VYTORIN is indicated for the treatment of high LDL cholesterol in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. In addition, no Cholesterol lipitor drugs including VYTORIN are approved for use in reducing CRP. Results from this study also showed greater mean HDL-C increases across the treatment periods in patients taking ezetimibe with simvastatin (mean of 10 percent, range 8 to 12 percent) compared to patients taking atorvastatin alone (mean of 6 percent, range 5 to 8 percent). Women who are of childbearing age (unless highly unlikely to conceive), are nursing or who are pregnant should not take VYTORIN. This cholesterol lipitor is really a big deal, Dr. Nevertheless, other experts caution that it is too soon to rewrite federal guidelines, although that may be in cholesterol lipitor the offing as several new studies tackle this issue in the next few years. Around 2,500 counterfeit packs had already been consumed or discarded by NHS patients. Specifically, 59. Cholesterol lipitor 7 percent of patients taking VYTORIN 10/20 mg reached this LDL cholesterol level versus 21. 5 percent of patients taking Lipitor 10 mg and 35. 0 percent taking Lipitor 20 mg (p<0. Cholesterol lipitor 001 for both comparisons).